Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome

British Journal of Haematology

Volumn 132, Issue 3, 2006, Pages 286-292

  Robyn, Jamie ^a   Lemery, Steven ^b   Philip McCoy, J ^b   Kubofcik, Joseph ^a   Kim, Yae Jean ^a   Pack, Svetlana ^a   Nutman, Thomas B ^a   Dunbar, Cynthia ^b   Klion, Amy D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Clonal; Fusion gene; Hypereosinophilia; Imatinib; Lineage

Indexed keywords

FIP 1 LIKE 1 PROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; FIP1L1 PDGFRA FUSION PROTEIN, HUMAN; FIP1L1-PDGFRA FUSION PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL POPULATION; CELL SPECIFICITY; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENETIC ANALYSIS; GENETIC LINE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; MAST CELL; MONOCYTE; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; CELL CULTURE; EOSINOPHIL; GENETICS; IMMUNOLOGY; MALE; METHODOLOGY; PHYSIOLOGY;

ANTIGENS, CD; B-LYMPHOCYTES; CELLS, CULTURED; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MAST CELLS; MONOCYTES; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NEUTROPHILS; ONCOGENE PROTEINS, FUSION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 33644868101     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05863.x     Document Type: Article

References (26)

1. Akin C. 2003 Multilineage hematopoietic involvement in systemic mastocytosis Leukemia Research 27 877 878
2. Akin C. Kirshenbaum A.S. Semere T. Worobec A.S. Scott L.M. Metcalfe D.D. 2000 Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis Experimental Hematology 28 140 147
3. Cools J. DeAngelo D.J. Gotlib J. Stover E.H. Legare R.D. Cortes J. Kutok J. Clark J. Galinsky I. Griffin J.D. Cross N.C. Tefferi A. Malone J. Alam R. Schrier S.L. Schmid J. Rose M. Vandenberghe P. Verhoef G. Boogaerts M. Wlodarska I. Kantarjian H. Marynen P. Coutre S.E. Stone R. Gilliland D.G. 2003a A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome New England Journal of Medicine 348 1201 1214
4. Cools J. Stover E.H. Boulton C.L. Gotlib J. Legare R.D. Amaral S.M. Curley D.P. Duclos N. Rowan R. Kutok J.L. Lee B.H. Williams I.R. Coutre S.E. Stone R.M. DeAngelo D.J. Marynen P. Manley P.W. Meyer T. Fabbro D. Neuberg D. Weisberg E. Griffin J.D. Gilliland D.G. 2003b PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease Cancer Cell 3 459 469
5. Cools J. Quentmeier H. Huntly B.J. Marynen P. Griffin J.D. Drexler H.G. Gilliland D.G. 2004 The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia Blood 103 2802 2805
6. Fleiss J. Cuzick J. 1979 The reliability of dichotomous judgements: unequal numbers of judges per subject Applied Psychological Measurement 3 537 542
7. Gessner A. Mohrs K. Mohrs M. 2005 Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production Journal of Immunology 174 1063 1072
8. Gilliland G. Cools J. Stover E.H. Wlodarska I. Marynen P. 2004 FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis Hematology Journal 5 Suppl. 3 S133 S137
9. Gotlib J. Cools J. Malone III. J.M. Schrier S.L. Gilliland D.G. Coutre S.E. 2004 The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management Blood 103 2879 2891
10. Griffin J.H. Leung J. Bruner R.J. Caligiuri M.A. Briesewitz R. 2003 Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome Proceedings of the National Academy of Sciences USA 100 7830 7835
11. Kirshenbaum A.S. Goff J.P. Semere T. Foster B. Scott L.M. Metcalfe D.D. 1999 Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13) Blood 94 2333 2342
12. Klion A.D. Noel P. Akin C. Law M.A. Gilliland D.G. Cools J. Metcalfe D.D. Nutman T.B. 2003 Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness Blood 101 4660 4666
13. Klion A.D. Robyn J. Akin C. Noel P. Brown M. Law M. Metcalfe D.D. Dunbar C. Nutman T.B. 2004 Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome Blood 103 473 478
14. Migliaccio A.R. Rana R.A. Sanchez M. Lorenzini R. Centurione L. Bianchi L. Vannucchi A.M. Migliaccio G. Orkin S.H. 2003 GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant Journal of Experimental Medicine 197 281 296
15. Musto P. Falcone A. Sanpaolo G. Bodenizza C. Perla G. Minervini M.M. Cascavilla N. Dell'Olio M. La S.A. Mantuano S. Melillo L. Nobile M. Scalzulli P.R. Bisceglia M. Carella A.M. 2004 Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis Leukemia and Lymphoma 45 1219 1222
16. Pack S.D. Karkera J.D. Zhuang Z. Pak E.D. Balan K.V. Hwu P. Park W.S. Pham T. Ault D.O. Glaser M. Liotta L. tera-Wadleigh S.D. Wadleigh R.G. 1999 Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations Genes Chromosomes and Cancer 25 160 168
17. Pardanani A. Reeder T. Li C.Y. Tefferi A. 2003 Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia Leukemia Research 27 883 885
18. Pardanani A. Brockman S.R. Paternoster S.F. Flynn H.C. Ketterling R.P. Lasho T.L. Ho C.L. Li C.Y. Dewald G.W. Tefferi A. 2004 FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia Blood 104 3038 3045
19. Raskind W.H. Steinmann L. Najfeld V. 1998 Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer Leukemia 12 108 116
20. Reeder T.L. Bailey R.J. Dewald G.W. Tefferi A. 2003 Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia Blood 101 1981 1983
21. Spivak J.L. 2004 The chronic myeloproliferative disorders: clonality and clinical heterogeneity Seminars in Hematology 41 1 5
22. Takahashi N. Miura I. Saitoh K. Miura A.B. 1998 Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization Blood 92 4758 4763
23. Tefferi A. Schad C.R. Pruthi R.K. Ahmann G.J. Spurbeck J.L. Dewald G.W. 1995 Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia Cancer Genetics and Cytogenetetics 83 61 64
24. Tefferi A. Lasho T.L. Brockman S.R. Elliott M.A. Dispenzieri A. Pardanani A. 2004 FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia Haematologica 89 871 873
25. Yu C. Cantor A.B. Yang H. Browne C. Wells R.A. Fujiwara Y. Orkin S.H. 2002 Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo Journal of Experimental Medicine 195 1387 1395
26. Zou G. Donner A. 2004 Confidence interval estimation of the intraclass correlation coefficient for binary outcome data Biometrics 60 807 811